Across TCGA pan-cancer cohorts, FAM106DP RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FAM106DP’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where FAM106DP RNA is repressed in tumor relative to normal tissue. In most cancer types FAM106DP is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.
COAD, THCA, and LUSC are the cancer types where FAM106DP tumor–normal differential expression is most reproducible.